Research team led by BME's Cheng Zhu probes the underlying mechanisms of PD-1 checkpoint inhibitor therapy. By: Jerry Grillo (jerry.grillo@ibb.gatech.edu) Friday, 08 November 2024 Wallace H. Coulter Department of Biomedical Engineering Blank Space (small)(text and background only visible when logged in)
